Renal Cancer
Comparative analysis of trifecta and pentafecta outcomes in T1a and T1b renal tumors following robotic partial nephrectomy: a retrospective study.
February 21, 2025
Oncologists' and urologists' preferences for adjuvant therapy in renal cell carcinoma: a discrete-choice experiment.
February 21, 2025
Differentiating between renal medullary and clear cell renal carcinoma with a machine learning radiomics approach.
February 19, 2025
Time trend and age-period-cohort effect on kidney cancer mortality in spain, 1983-2022.
February 18, 2025
Soluble TIM-3, likely produced by myeloid cells, predicts resistance to immune checkpoint inhibitors in metastatic clear cell renal cell carcinoma.
February 17, 2025
A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma.
February 14, 2025
Pathogenicity of germline VHL variants is associated with renal cell carcinoma size in von Hippel-Lindau disease.
February 14, 2025
Management of oligometastatic and oligoprogressive renal cell carcinoma: an updated review.
February 13, 2025
Patient preferences for adjuvant therapy in renal cell carcinoma: a discrete-choice experiment.
February 13, 2025
Organoids as Sophisticated Tools for Renal Cancer Research: Extensive Applications and Promising Prospects.
February 12, 2025
Belzutifan for the treatment of renal cell carcinoma.
February 12, 2025
Oncogenic TFE3 fusions drive OXPHOS and confer metabolic vulnerabilities in translocation renal cell carcinoma.
February 11, 2025